multidisciplinary therapy of pancreas cancer · case study question-and-answer session panel...
TRANSCRIPT
Multidisciplinary Therapy of Pancreas Cancer: recent advances and emerging paradigms
May 8-9, 2020The University of Texas MD Anderson Cancer CenterThe Sheikh Zayed Bin Sultan Al Nahyan Building (Zayed Building)Conference Center, Floor 26565 MD Anderson BoulevardHouston, Texas 77030
educational objectives
After attending the conference, participants should be able to
Implement genetic testing of patients and family members to screen for
those who are at risk for developing pancreatic cancer and other cancers
(knowledge, competence, performance, patient outcomes);
Evaluate, counsel and treat patients with pancreatic cancer at all stages of
disease (locally advanced, resectable, borderline resectable, metastatic)
(knowledge, competence, performance);
Provide a comprehensive understanding of innovative and emerging cancer
therapies, inclusive of the side effects, to the cancer patient (knowledge,
competence, performance, patient outcomes); and
Apprise fellow clinicians and healthcare providers of emerging paradigms
of the latest clinical trials and supportive care (knowledge, competence).
target audience
This conference should be of interest to Physicians, Advanced Practice
Providers, Nurses, Researchers, Fellows and Trainees.
goal
The goal of this activity is
to disseminate information
about the treatments and care
provided for pancreatic cancer
patients and the new research
and technologies implemented,
resulting in improved patient
outcomes.
educational methods
Lectures
Case Study
Question-and-Answer Session
Panel Discussion
evaluation
A course evaluation survey will provide
participants with the opportunity to
comment on the value of the program
content to their practice decisions,
performance improvement activities, or
possible impact on patient health status.
Participants will also have the opportunity
to comment on any perceived commercial
bias in the presentations as well as to
identify future educational topics.
accreditation/ credit designation
The University of Texas MD Anderson
Cancer Center is accredited by the
Accreditation Council for Continuing
Medical Education (ACCME) to provide
continuing medical education for
physicians.
The University of Texas MD Anderson
Cancer Center designates this live activity
for a maximum of 12.00 AMA PRA
Category 1 Credits™. Physicians should
claim only the credit commensurate
with the extent of their participation in
the activity.
abim maintenance of certification (moc)
Successful completion of this CME
activity, which includes participation in
the evaluation component, enables the
participant to earn up to 12.00 Medical
Knowledge MOC points in the American
Board of Internal Medicine’s (ABIM)
Maintenance of Certification (MOC)
program. Participants will earn MOC
points equivalent to the amount of CME
credits claimed for the activity. It is the
CME activity provider’s responsibility to
submit participant completion information
to ACCME for the purpose of granting
ABIM MOC credit.
In order to receive MOC points, you will
need to pass the post-test with a score
of 70% or higher. You will be able to take
the test as many times as you need to in
order to pass.
Participant completion data will be shared
with and transmitted to the ACCME on
the participant’s behalf.
ethics
The “Supportive Care” session has been
designated by The University of Texas MD
Anderson Cancer Center for 1.25 AMA
PRA Category 1 Credits™ in medical
ethics and/or professional responsibility.
cme certificates and attendance verification certificates
Certificates awarding AMA PRA Category
1 Credit™ or certificates documenting
attendance will be emailed when an
individual completed the online CME
Verification and Evaluation Questionnaire
process after the conference.
A record of attendance (certificate) will
be available online to other health care
professionals for requesting credits in
accordance with state nursing boards,
specialty societies, or other professional
associations.
md anderson program committee members
Robert A. Wolff, MD, Co-ChairGastrointestinal Medical Oncology
Matthew HG Katz, MD, Co-ChairSurgical Oncology
Anirban Maitra, MBBSTranslational Molecular, Pathology
Shubham Pant, MBBSInvestigational Cancer Therapeutics
Emma Brae Holliday, MDRadiation Oncology
Sonya TennantSheikh Ahmed Center for Pancreatic Cancer Research
Felisha EstelleCME/Conference Management
Kelley GilpinCME/Conference Management
Pamela Papadopoulos, PhDSheikh Ahmed Center for Pancreatic Cancer Research
Program Agendafriday, may 8, 20203:00 pm Registration
3:30 Welcome & Introductions Robert A. Wolff, MD
3:45 Keynote : Genetics and Targeting Opportunities in Pancreas Cancer Eileen O’Reilly, MD
Translational Talks
4:30 The Role of the Tumor and Gut Microbiome in Pancreatic Cancer Florencia McAllister, MD
5:00 Radiomic Features of Pancreatic Cancer Eugene Koay, MD, PhD
5:30 Liquid Biopsies and Measurement of Therapeutic Response Anirban Maitra, MBBS
6:00 Opportunities for Innovation Through Radiotherapy Clinical Trials for Pancreatic Cancer: The MDACC Experience Cullen Taniguchi, MD, PhD
6:30 Closing Remarks Emma Holliday, MD
6:45 Reception Dinner
saturday, may 9, 20208:00 am Registration and Continental Breakfast
8:30 Welcome & Introductions Matthew HG Katz, MD
8:45 Value Keys from the PC Patient’s Perspective Shannon Magee
9:00 Neoadjuvant Treatment Paradigms for Borderline Resectable and Locally Advanced Pancreatic Cancer: Sequencing and the Role of Radiation Theodore Hong, MD
Current Controversies
9:30 Preoperative vs. Postoperative Therapy for Resectable Pancreatic Cancer Matthew HG Katz, MD Robert A. Wolff, MD
10:00 Should We Treat Oligometastatic Pancreatic Cancer with Local Therapies Chad Tang, MD Ryan Huey, MD
10:30 Break
Multimodality Treatment Paradigms and New Innovations
10:45 Radiographic Staging of Pancreatic Cancer Eric Tamm, MD
11:00 The Role of a Gastroenterologist in Managing Pancreatic Cancer in a Multidisciplinary Approach Jeffrey H. Lee, MD
11:15 Endoscopic Delivery of Novel Therapies in Pancreatic Cancer Manoop Bhutani, MBBS
11:30 Management of Pancreatic Cysts Michael Kim, MD
11:45 Lunch (provided)
12:45 pm Enhanced Recovery after Pancreatic Surgery Ching-Wei Tzeng, MD
1:00 Strategic Approach to Building a Robotic Pancreatic Surgery Program at MD Anderson Naruhiko Ikoma, MD
1:15 Surgery for Borderline Resectable Pancreas Cancer Matthew HG Katz, MD
1:30 “Who, When and How Much?” Current Controversies in Radiation for Pancreatic Cancer Emma Holliday, MD
1:45 Multidisciplinary Tumor Board / Case Study 1 Michael Kim, MD; Michael Overman, MD; and Cullen Taniguchi, MD, PhD
2:00 Break
2:15 Systemic Treatment for Metastatic Pancreatic Cancer, are We Making Headway? Michael Overman, MD
2:30 Update on Novel Targeted Therapies for Pancreas Cancer David Fogelman, MD
2:45 Innovative Early Stage Drug Development Shubham Pant, MBBS
3:00 Multidisciplinary Tumor Board / Case Study 2 Ching-Wei Tzeng, MD; David Fogelman, MD; and Eugene Koay, MD, PhD
3:15 Break
Supportive Care and Survivorship
3:30 Exercise and Pancreatic Cancer Survivorship Nathan Parker, PhD
3:45 Optimizing Nutrition Status in Patients with Pancreatic Cancer Maria Petzel, MBS
4:00 Supportive/Palliative Care for Patients with Pancreatic Cancer Yvonne Heung, MD
4:15 Closing Remarks Shubham Pant, MBBS
4:20 Adjourn
md anderson faculty
guest facultyTheodore S. Hong, MDDirector, Gastrointestinal Service, Radiation Oncology, Massachusetts General Hospital Associate Clinical Director, Radiation Oncology, Massachusetts General Hospital Boston, Massachusetts
Shannon MageePatient Advocate Austin, Texas
Eileen M. O’Reilly, MDWinthrop Rockefeller Endowed Chair in Medical Oncology Section Head, Hepatopancreaticobiliary & Neuroendocrine Cancers Gastrointestinal Oncology Service Associate Director, David M. Rubenstein Center for Pancreatic Cancer Research Attending Physician, Member, Memorial Sloan Kettering Cancer Center, New York, New York Professor of Medicine, Weill Cornell Medical College, New York, New York
Manoop Bhutani, MBBS Professor Gastroenterology, Hepatology & Nutrition
David Fogelman, MD Associate Professor Gastrointestinal Medical Oncology
Yvonne Heung, MD Assistant Professor Palliative Care Medicine
Emma Holliday, MD Assistant Professor, Radiation Oncology
Ryan Huey, MD Assistant Professor Gastrointestinal Medical Oncology
Naruhiko Ikoma, MD Assistant Professor, Surgical Oncology
Matthew HG Katz, MD Associate Professor, Surgical Oncology
Michael Kim, MD Assistant Professor, Surgical Oncology
Eugene Koay, MD, PhD Associate Professor, Radiation Oncology
Jeffrey H. Lee, MD Professor Gastroenterology, Hepatology & Nutrition
Anirban Maitra, MBBS Professor, Pathology, Anatomical
Florencia McAllister, MD Assistant Professor Clinical Cancer Prevention
Michael Overman, MD Professor Gastrointestinal Medical Oncology
Shubham Pant, MBBS Associate Professor Investigational Cancer Therapeutics
Nathan Parker, PhD Instructor, Behavioral Science
Maria Petzel, BS Sr. Clinical Dietitian, Clinical Nutrition
Eric Tamm, MD Professor, Abdominal Imaging
Chad Tang, MD Assistant Professor, Radiation Oncology
Cullen Taniguchi, MD, PhD Assistant Professor, Radiation Oncology
Ching-Wei Tzeng, MD Associate Professor, Surgical Oncology
Robert A. Wolff, MD Professor Gastrointestinal Medical Oncology
registration information
On-site registration for the Multidisciplinary Therapy of Pancreas Cancer Conference opens
at 3:00 p.m. on Friday, May 8, 2020. The opening session will begin at 3:30 p.m. on Friday,
May 8, 2020 and the conference will adjourn at 4:20 p.m., Saturday, May 9, 2020.
Advanced registration is encouraged as space and materials are limited. Please see
registration form for applicable fees.
The deadline for advanced registration is Friday, April 23, 2020.
There are three ways to register:
1. On-line at www.mdanderson.org/conferences
2. Fax to: 713-794-1724
3. Mail to: Department of CME/Conference Management
Unit 1781
The University of Texas MD Anderson Cancer Center
P.O. Box 301407
Houston, TX 77230-1407
We accept the following forms of payment:
1. Check (payable through U.S. banks only)
2. Money Order
3. Credit Cards (MasterCard, VISA, and American Express)
4. Cash (on-site registration only)
When registering online a confirmation letter (receipt) will be automatically emailed to the
email address you list on the registration form. The confirmation letter will serve as your
receipt. If you register by fax or mail, a confirmation letter will be emailed to you within ten
working days of receipt of your fee.
The full conference registration fee includes the tuition, final program, continental
breakfast, breaks, lunch and welcome reception.
refund/cancellation policy
The registration fee, minus a $50
administrative handling fee, is refundable
if a written request is received on or
before April 23, 2020. No refunds will be
granted after that date. The request for a
registration refund must include the tax
identification number of the company or
institution if registration was paid by a
company or institution check.
The Department of CME/Conference
Management reserves the right to cancel
activities prior to the scheduled date, if
low enrollment or other circumstances
make it necessary. Each registrant will be
notified by mail, e-mail, or at the phone
or fax numbers given on the registration
form.
In case of activity cancellation, liability
of the Department of CME/Conference
Management is limited to the registration
fee. The Department of CME/Conference
Management will refund the full
registration fee. The Department of CME/
Conference Management reserves the
right to limit the number of participants
in a program and is not responsible for
any expenses incurred by an individual
whose registration is not confirmed and
for whom space is not available.
For additional information, contact
the Department of CME/Conference
Management at 713-792-2223 or toll free
at 866-849-5866.
special assistance
Contact the Department of CME/
Conference Management at 713-792-
2223 or toll free at 866-849-5866 if
you have any special dietary or ADA
accommodation needs.
accommodations
A block of rooms has been reserved for
conference attendees at the Houston
Marriott Medical Center Hotel, 6580
Fannin Street, Houston, Texas 77030.
Early hotel reservation is suggested.
The hotel phone number is
713-796-0080
Toll Free 1-800-228-9290.
When you make reservations be sure
to mention “Multidisciplinary Therapy
of Pancreas Cancer” to be assured of
receiving the special meeting rate of
$109.00 single or double occupancy.
Please add 17% Texas state and local
taxes.
Room Reservation Website Link:
Book your group rate for
Multidisciplinary Therapy of Pancreas
Cancer Room Block or use the bitly link
https://bit.ly/35mpOfq
Reservations and deposits received
after Thursday, April 23, 2020 will be
confirmed if space is available and at
current hotel published guest room rates.
groundtransportation
Houston is served by two airports, George
Bush Intercontinental (IAH) and William
P. Hobby (HOU). The following forms of
ground transportation are available to and
from the airports to the Medical Center.
Uber and Lyft
Yellow Cab 713-236-1111
Fiesta Cab 713-225-2666
THIS
IS N
OT A
SEL
F-M
AILE
R - A
ddre
ss to
: M
ultid
isci
plin
ary
Ther
apy
of P
ancr
eas
Canc
er:
rec
ent
ad
va
nc
es a
nd e
mer
gin
g p
ar
ad
igm
sM
ay 8
-9, 2
020
Depa
rtmen
t of C
ME/
Conf
eren
ce M
anag
emen
t – U
nit 1
781
The
Unive
rsity
of T
exas
MD
Ande
rson
Can
cer C
ente
r PO
Box
301
407,
Hou
ston
, TX
7723
0-14
07or
fax t
o 71
3-79
4-17
24
Mak
e ch
eck o
r mon
ey o
rder
pay
able
to:
The
Univ
ersi
ty o
f Tex
as M
D An
ders
on C
ance
r Cen
ter
Regi
stra
tion
Fees
Phys
icia
ns/S
cien
tists
Pos
tmar
ked
on o
r bef
ore
April
23,
202
0 . .
. . . .
.$20
0 .00
Pos
tmar
ked
afte
r Apr
il 23
, 202
0 . .
. . . .
. . . .
. . . .
$250
.00
Nur
ses/
APPs
Pos
tmar
ked
on o
r bef
ore
April
23,
202
0 . .
. . . .
. .$7
5 .00
Pos
tmar
ked
afte
r Apr
il 23
, 202
0 . .
. . . .
. . . .
. . . .
$125
.00
Stud
ents
/Fel
low
s/Re
side
nts
Pos
tmar
ked
on o
r bef
ore
April
23,
202
0 . .
. . . .
. .$5
0 .00
Pos
tmar
ked
afte
r Apr
il 23
, 202
0 . .
. . . .
. . . .
. . . .
$100
.00
MDA
CC F
acul
ty P
ostm
arke
d on
or b
efor
e Ap
ril 2
3, 2
020
. . . .
. . .$
150 .
00 P
ostm
arke
d af
ter A
pril
23, 2
020
. . . .
. . . .
. . . .
. .$2
00 .0
0M
DACC
Nur
ses/
APPs
Pos
tmar
ked
on o
r bef
ore
April
23,
202
0 . .
. . . .
. .$5
0 .00
Pos
tmar
ked
afte
r Apr
il 23
, 202
0 . .
. . . .
. . . .
. . . .
$100
.00
MDA
CC S
tude
nts/
Fello
ws/
Resi
dent
s P
ostm
arke
d on
or b
efor
e Ap
ril 2
3, 2
020
. . . .
. . . .
$25 .
00 P
ostm
arke
d af
ter A
pril
23, 2
020
. . . .
. . . .
. . . .
. . .$
75 .0
0At
tend
ing
Frid
ay R
ecep
tion?
. . . .
. . . .
. . . .
. .
Yes
N
o
The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone
who is in a position to control the content of an educational activity must disclose all relevant
financial relationships with any commercial interest that could potentially affect the information
presented. MD Anderson also requires that all faculty disclose any unlabeled use or investigational
use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific
disclosure will be made to the participants prior to the educational activity.
Agendas are subject to change because we are always striving to improve the quality of your
educational experience. MD Anderson may substitute faculty with comparable expertise on rare
occasions necessitated by illness, schedule conflicts, and so forth.
Photographing, audio taping and videotaping are prohibited.
Please let us know what specific topics, issues or questions you wish
to see addressed or emphasized in this activity. Fax or e-mail CME/
Conference Management. All responses will be forwarded to the Program
Chairs for consideration.
CO
NFE
REN
CE
REG
ISTR
ATI
ON
- D12
2369
Mul
tidis
cipl
inar
y Th
erap
y of
Pan
crea
s Ca
ncer
May
8-9
, 202
0La
st N
ame
Firs
tM
IHi
ghes
t Deg
ree
Depa
rtmen
t (in
clud
e un
it no
.) Sp
ecia
lty
Inst
itutio
n
MD
Ande
rson
Em
ploy
ee ID
No.
(req
uire
d fo
r all
MDA
CC e
mpl
oyee
s):
Phys
icia
nn
Yes
n N
o
Stre
et
City
Stat
e/Fo
reig
n Co
untry
/Zip
or M
ail C
ode
Dayt
ime
Phon
e (w
ith a
rea
code
) Ce
ll Ph
one
(with
are
a co
de)
Fax
(with
are
a co
de)
E-m
ail A
ddre
ss (p
leas
e pr
int)
Emer
genc
y Co
ntac
tPh
one
(with
are
a co
de)
Cred
it Ca
rd H
olde
r Nam
e (F
irst/
Last
) Ch
arge
the
follo
win
g:n
VIS
A n
MC n
AM
EX
Cred
it Ca
rd N
umbe
rEx
pira
tion
Date
Secu
rity
Code
/CVV
/CSV
Cred
it Ca
rd H
olde
r Bill
ing
Addr
ess
& Z
IP C
ode
MD
And
erso
n In
terd
epar
tmen
tal T
rans
fer (
IDT)
No .
: *Fu
nd G
roup
90
will
not
be
acce
pted
Bus
ines
s U
nit
Dep
artm
ent
Fund
Gro
up*
Fund
Fund
Typ
e
Aut
hori
zed
Sign
atur
e RE
QU
IRED
for C
RED
IT C
ARD
or I
DT
IDT
Appr
over
Nam
e (F
irst/L
ast)
plea
se p
rint
THIS
IS N
OT A
SEL
F-M
AILE
R - A
ddre
ss to
: M
ultid
isci
plin
ary
Ther
apy
of P
ancr
eas
Canc
er:
rec
ent
ad
va
nc
es a
nd e
mer
gin
g p
ar
ad
igm
sM
ay 8
-9, 2
020
Depa
rtmen
t of C
ME/
Conf
eren
ce M
anag
emen
t – U
nit 1
781
The
Unive
rsity
of T
exas
MD
Ande
rson
Can
cer C
ente
r PO
Box
301
407,
Hou
ston
, TX
7723
0-14
07or
fax t
o 71
3-79
4-17
24
Mak
e ch
eck o
r mon
ey o
rder
pay
able
to:
The
Univ
ersi
ty o
f Tex
as M
D An
ders
on C
ance
r Cen
ter
Regi
stra
tion
Fees
Phys
icia
ns/S
cien
tists
Pos
tmar
ked
on o
r bef
ore
April
23,
202
0 . .
. . . .
.$20
0 .00
Pos
tmar
ked
afte
r Apr
il 23
, 202
0 . .
. . . .
. . . .
. . . .
$250
.00
Nur
ses/
APPs
Pos
tmar
ked
on o
r bef
ore
April
23,
202
0 . .
. . . .
. .$7
5 .00
Pos
tmar
ked
afte
r Apr
il 23
, 202
0 . .
. . . .
. . . .
. . . .
$125
.00
Stud
ents
/Fel
low
s/Re
side
nts
Pos
tmar
ked
on o
r bef
ore
April
23,
202
0 . .
. . . .
. .$5
0 .00
Pos
tmar
ked
afte
r Apr
il 23
, 202
0 . .
. . . .
. . . .
. . . .
$100
.00
MDA
CC F
acul
ty P
ostm
arke
d on
or b
efor
e Ap
ril 2
3, 2
020
. . . .
. . .$
150 .
00 P
ostm
arke
d af
ter A
pril
23, 2
020
. . . .
. . . .
. . . .
. .$2
00 .0
0M
DACC
Nur
ses/
APPs
Pos
tmar
ked
on o
r bef
ore
April
23,
202
0 . .
. . . .
. .$5
0 .00
Pos
tmar
ked
afte
r Apr
il 23
, 202
0 . .
. . . .
. . . .
. . . .
$100
.00
MDA
CC S
tude
nts/
Fello
ws/
Resi
dent
s P
ostm
arke
d on
or b
efor
e Ap
ril 2
3, 2
020
. . . .
. . . .
$25 .
00 P
ostm
arke
d af
ter A
pril
23, 2
020
. . . .
. . . .
. . . .
. . .$
75 .0
0At
tend
ing
Frid
ay R
ecep
tion?
. . . .
. . . .
. . . .
. .
Yes
N
o
Depa
rtmen
t of C
ME/
Conf
eren
ce M
anag
emen
t- Un
it 17
81Th
e Un
iver
sity
of T
exas
MD
Ande
rson
Can
cer C
ente
r17
6700
/30/
1223
69/4
1PO
Box
301
407
Hous
ton,
TX
7723
0-14
07
Non
-Pro
fit O
rg.
U.S.
Pos
tage
P A
I DHo
usto
n, T
XPe
rmit
No.
705
2